Cargando…

Cost of surviving sepsis: a novel model of recovery from sepsis in Drosophila melanogaster

BACKGROUND: Multiple organ failure, wasting, increased morbidity, and mortality following acute illness complicates the health span of patients surviving sepsis. Persistent inflammation has been implicated, and it is proposed that insulin signaling contributes to persistent inflammatory signaling du...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaynar, Ata Murat, Bakalov, Veli, Laverde, Silvia Martinez, Cambriel, Amélie I. F., Lee, Byoung-Hoon, Towheed, Atif, Gregory, Alyssa D., Webb, Steven A. R., Palladino, Michael J., Bozza, Fernando A., Shapiro, Steven D., Angus, Derek C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720623/
https://www.ncbi.nlm.nih.gov/pubmed/26791145
http://dx.doi.org/10.1186/s40635-016-0075-4
_version_ 1782411101165584384
author Kaynar, Ata Murat
Bakalov, Veli
Laverde, Silvia Martinez
Cambriel, Amélie I. F.
Lee, Byoung-Hoon
Towheed, Atif
Gregory, Alyssa D.
Webb, Steven A. R.
Palladino, Michael J.
Bozza, Fernando A.
Shapiro, Steven D.
Angus, Derek C.
author_facet Kaynar, Ata Murat
Bakalov, Veli
Laverde, Silvia Martinez
Cambriel, Amélie I. F.
Lee, Byoung-Hoon
Towheed, Atif
Gregory, Alyssa D.
Webb, Steven A. R.
Palladino, Michael J.
Bozza, Fernando A.
Shapiro, Steven D.
Angus, Derek C.
author_sort Kaynar, Ata Murat
collection PubMed
description BACKGROUND: Multiple organ failure, wasting, increased morbidity, and mortality following acute illness complicates the health span of patients surviving sepsis. Persistent inflammation has been implicated, and it is proposed that insulin signaling contributes to persistent inflammatory signaling during the recovery phase after sepsis. However, mechanisms are unknown and suitable pre-clinical models are lacking. We therefore developed a novel Drosophila melanogaster model of sepsis to recapitulate the clinical course of sepsis, explored inflammation over time, and its relation to impaired mobility, metabolic disturbance, and changes in lifespan. METHODS: We used wild-type (WT), Drosomycin-green fluorescent protein (GFP), and NF-κB-luc reporter male Drosophila melanogaster 4–5 days of age (unmanipulated). We infected Drosophila with Staphylococcus aureus (infected without treatment) or pricked with aseptic needles (sham). Subsets of insects were treated with oral linezolid after the infection (infected with antibiotics). We assessed rapid iterative negative geotaxis (RING) in all the groups as a surrogate for neuromuscular functional outcome up to 96 h following infection. We harvested the flies over the 7-day course to evaluate bacterial burden, inflammatory and metabolic pathway gene expression patterns, NF-κB translation, and metabolic reserve. We also followed the lifespan of the flies. RESULTS: Our results showed that when treated with antibiotics, flies had improved survival compared to infected without treatment flies in the early phase of sepsis up to 1 week (81 %, p = 0.001). However, the lifespan of infected with antibiotics flies was significantly shorter than that of sham controls (p = 0.001). Among infected with antibiotic sepsis survivors, we observed persistent elevation of NF-κB in the absence of any obvious infection as shown by culturing flies surviving sepsis. In the same group, geotaxis had an early (18 h) and sustained decline compared to its baseline. Geotaxis in infected with antibiotics sepsis survivors was significantly lower than that in sham and age-matched unmanipulated flies at 18 and 48 h. Expression of antimicrobial peptides (AMP) remained significantly elevated over the course of 7 days after sepsis, especially drosomycin (5.7-fold, p = 0.0145) on day 7 compared to that of sham flies. Infected with antibiotics flies had a trend towards decreased Akt activation, yet their glucose stores were significantly lower than those of sham flies (p = 0.001). Sepsis survivors had increased lactate levels and LDH activity by 1 week, whereas ATP and pyruvate content was similar to that of the sham group. CONCLUSIONS: In summary, our model mimics human survivors of sepsis with persistent inflammation, impaired motility, dysregulated glucose metabolism, and shortened lifespan. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40635-016-0075-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4720623
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-47206232016-01-31 Cost of surviving sepsis: a novel model of recovery from sepsis in Drosophila melanogaster Kaynar, Ata Murat Bakalov, Veli Laverde, Silvia Martinez Cambriel, Amélie I. F. Lee, Byoung-Hoon Towheed, Atif Gregory, Alyssa D. Webb, Steven A. R. Palladino, Michael J. Bozza, Fernando A. Shapiro, Steven D. Angus, Derek C. Intensive Care Med Exp Research BACKGROUND: Multiple organ failure, wasting, increased morbidity, and mortality following acute illness complicates the health span of patients surviving sepsis. Persistent inflammation has been implicated, and it is proposed that insulin signaling contributes to persistent inflammatory signaling during the recovery phase after sepsis. However, mechanisms are unknown and suitable pre-clinical models are lacking. We therefore developed a novel Drosophila melanogaster model of sepsis to recapitulate the clinical course of sepsis, explored inflammation over time, and its relation to impaired mobility, metabolic disturbance, and changes in lifespan. METHODS: We used wild-type (WT), Drosomycin-green fluorescent protein (GFP), and NF-κB-luc reporter male Drosophila melanogaster 4–5 days of age (unmanipulated). We infected Drosophila with Staphylococcus aureus (infected without treatment) or pricked with aseptic needles (sham). Subsets of insects were treated with oral linezolid after the infection (infected with antibiotics). We assessed rapid iterative negative geotaxis (RING) in all the groups as a surrogate for neuromuscular functional outcome up to 96 h following infection. We harvested the flies over the 7-day course to evaluate bacterial burden, inflammatory and metabolic pathway gene expression patterns, NF-κB translation, and metabolic reserve. We also followed the lifespan of the flies. RESULTS: Our results showed that when treated with antibiotics, flies had improved survival compared to infected without treatment flies in the early phase of sepsis up to 1 week (81 %, p = 0.001). However, the lifespan of infected with antibiotics flies was significantly shorter than that of sham controls (p = 0.001). Among infected with antibiotic sepsis survivors, we observed persistent elevation of NF-κB in the absence of any obvious infection as shown by culturing flies surviving sepsis. In the same group, geotaxis had an early (18 h) and sustained decline compared to its baseline. Geotaxis in infected with antibiotics sepsis survivors was significantly lower than that in sham and age-matched unmanipulated flies at 18 and 48 h. Expression of antimicrobial peptides (AMP) remained significantly elevated over the course of 7 days after sepsis, especially drosomycin (5.7-fold, p = 0.0145) on day 7 compared to that of sham flies. Infected with antibiotics flies had a trend towards decreased Akt activation, yet their glucose stores were significantly lower than those of sham flies (p = 0.001). Sepsis survivors had increased lactate levels and LDH activity by 1 week, whereas ATP and pyruvate content was similar to that of the sham group. CONCLUSIONS: In summary, our model mimics human survivors of sepsis with persistent inflammation, impaired motility, dysregulated glucose metabolism, and shortened lifespan. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40635-016-0075-4) contains supplementary material, which is available to authorized users. Springer International Publishing 2016-01-21 /pmc/articles/PMC4720623/ /pubmed/26791145 http://dx.doi.org/10.1186/s40635-016-0075-4 Text en © Kaynar et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Kaynar, Ata Murat
Bakalov, Veli
Laverde, Silvia Martinez
Cambriel, Amélie I. F.
Lee, Byoung-Hoon
Towheed, Atif
Gregory, Alyssa D.
Webb, Steven A. R.
Palladino, Michael J.
Bozza, Fernando A.
Shapiro, Steven D.
Angus, Derek C.
Cost of surviving sepsis: a novel model of recovery from sepsis in Drosophila melanogaster
title Cost of surviving sepsis: a novel model of recovery from sepsis in Drosophila melanogaster
title_full Cost of surviving sepsis: a novel model of recovery from sepsis in Drosophila melanogaster
title_fullStr Cost of surviving sepsis: a novel model of recovery from sepsis in Drosophila melanogaster
title_full_unstemmed Cost of surviving sepsis: a novel model of recovery from sepsis in Drosophila melanogaster
title_short Cost of surviving sepsis: a novel model of recovery from sepsis in Drosophila melanogaster
title_sort cost of surviving sepsis: a novel model of recovery from sepsis in drosophila melanogaster
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720623/
https://www.ncbi.nlm.nih.gov/pubmed/26791145
http://dx.doi.org/10.1186/s40635-016-0075-4
work_keys_str_mv AT kaynaratamurat costofsurvivingsepsisanovelmodelofrecoveryfromsepsisindrosophilamelanogaster
AT bakalovveli costofsurvivingsepsisanovelmodelofrecoveryfromsepsisindrosophilamelanogaster
AT laverdesilviamartinez costofsurvivingsepsisanovelmodelofrecoveryfromsepsisindrosophilamelanogaster
AT cambrielamelieif costofsurvivingsepsisanovelmodelofrecoveryfromsepsisindrosophilamelanogaster
AT leebyounghoon costofsurvivingsepsisanovelmodelofrecoveryfromsepsisindrosophilamelanogaster
AT towheedatif costofsurvivingsepsisanovelmodelofrecoveryfromsepsisindrosophilamelanogaster
AT gregoryalyssad costofsurvivingsepsisanovelmodelofrecoveryfromsepsisindrosophilamelanogaster
AT webbstevenar costofsurvivingsepsisanovelmodelofrecoveryfromsepsisindrosophilamelanogaster
AT palladinomichaelj costofsurvivingsepsisanovelmodelofrecoveryfromsepsisindrosophilamelanogaster
AT bozzafernandoa costofsurvivingsepsisanovelmodelofrecoveryfromsepsisindrosophilamelanogaster
AT shapirostevend costofsurvivingsepsisanovelmodelofrecoveryfromsepsisindrosophilamelanogaster
AT angusderekc costofsurvivingsepsisanovelmodelofrecoveryfromsepsisindrosophilamelanogaster